Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- Vlad Ratziu*
- , Stephen A. Harrison
- , Sven Francque
- , Pierre Bedossa
- , Philippe Lehert
- , Lawrence Serfaty
- , Manuel Romero-Gomez
- , J. rôme Boursier
- , Manal Abdelmalek
- , Steve Caldwell
- , Joost Drenth
- , Quentin M. Anstee
- , Dean Hum
- , Remy Hanf
- , Alice Roudot
- , Sophie Megnien
- , Bart Staels
- , Arun Sanyal
- , P. Mathurin
- , J. Gournay
*Corresponding author for this work
- Sorbonne Université
- Institut national de la santé et de la recherche médicale
- Brooke Army Medical Center
- University of Antwerp
- Hôpital Beaujon
- University of Melbourne
- Université catholique de Louvain
- Hospital Universitario de Valme
- Université d'Angers
- Duke University
- University of Virginia
- Radboud University Medical Center
- Newcastle University
- Genfit SA
- Université de Lille
- Virginia Commonwealth University
Research output: Contribution to journal › Article › Academic › peer-review